Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Science Translational Medicine
|
March 31, 2012
Improving treatment of HER2-positive cancers: opportunities and challenges
Howard M Stern
Nature Reviews. Cancer
|
July 2, 2003
Cancer genetics and drug discovery in the zebrafish
Howard M Stern, Leonard I Zon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab
Howard M Stern, Mary Padilla, Klaus Wagner, et al.
Cancer Cell
|
June 28, 2002
Zebrafish as a cancer model system
James F Amatruda, Jennifer L Shepard, Howard M Stern, et al.
Chemical Biology & Drug Design
|
November 16, 2006
A chemical genetic screen for cell cycle inhibitors in zebrafish embryos
Ryan D Murphey, Howard M Stern, Christian T Straub, et al.
Cancer Research
|
July 18, 2008
A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy
Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao, et al.
Blood
|
May 15, 2004
Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation
David Traver, Alissa Winzeler, Howard M Stern, et al.
International Journal of Oncology
|
September 12, 2006
Regulation of ERK3/MAPK6 expression by BRAF
Klaus P Hoeflich, Michael T Eby, William F Forrest, et al.
Nature Chemical Biology
|
December 24, 2005
Small molecules that delay S phase suppress a zebrafish bmyb mutant
Howard M Stern, Ryan D Murphey, Jennifer L Shepard, et al.
Genes, Chromosomes & Cancer
|
November 1, 2008
Construction and application of a zebrafish array comparative genomic hybridization platform
Jennifer L Freeman, Craig Ceol, Hui Feng, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Science Translational Medicine
|
March 31, 2012
Improving treatment of HER2-positive cancers: opportunities and challenges
Howard M Stern
Nature Reviews. Cancer
|
July 2, 2003
Cancer genetics and drug discovery in the zebrafish
Howard M Stern, Leonard I Zon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab
Howard M Stern, Mary Padilla, Klaus Wagner, et al.
Cancer Cell
|
June 28, 2002
Zebrafish as a cancer model system
James F Amatruda, Jennifer L Shepard, Howard M Stern, et al.
Chemical Biology & Drug Design
|
November 16, 2006
A chemical genetic screen for cell cycle inhibitors in zebrafish embryos
Ryan D Murphey, Howard M Stern, Christian T Straub, et al.
Cancer Research
|
July 18, 2008
A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy
Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao, et al.
Blood
|
May 15, 2004
Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation
David Traver, Alissa Winzeler, Howard M Stern, et al.
International Journal of Oncology
|
September 12, 2006
Regulation of ERK3/MAPK6 expression by BRAF
Klaus P Hoeflich, Michael T Eby, William F Forrest, et al.
Nature Chemical Biology
|
December 24, 2005
Small molecules that delay S phase suppress a zebrafish bmyb mutant
Howard M Stern, Ryan D Murphey, Jennifer L Shepard, et al.
Genes, Chromosomes & Cancer
|
November 1, 2008
Construction and application of a zebrafish array comparative genomic hybridization platform
Jennifer L Freeman, Craig Ceol, Hui Feng, et al.
Page
of 4